Topical delivery of selected growth factors
Van Niekerk, L.
Du Plessis, L.H.
Du Plessis, J.
MetadataShow full item record
Growth factors can benefit from controlled release admin- istration technologies (i.e. topical or transdermal delivery). When compared with other epithelial membranes, the skin has less enzymatic activity and so provides a more stable dosage medium and prolongs the delivery. The growth factors that were considered during this study are used for the treatment of alopecia (IGF-1, VEGF and KGF) and pigmentation (TNF-a & TGF-b)